Harmonic Newsroom

Analysts Are Bullish on Top Healthcare Stocks: Third Harmonic Bio, Inc. (THRD), Collegium Pharmaceutical (COLL)

TipRanksNov 8 19:45

Stifel Maintains Harmonic(HLIT.US) With Buy Rating, Maintains Target Price $23

Futu NewsNov 8 17:36

TD Cowen Remains a Buy on Third Harmonic Bio, Inc. (THRD)

TipRanksNov 8 01:08

Harmonic Is Maintained at Outperform by Northland Capital Markets

Dow JonesOct 29 20:33

Rosenblatt Securities Maintains Harmonic(HLIT.US) With Buy Rating, Cuts Target Price to $16

Futu NewsOct 29 20:31

Raymond James Downgrades Harmonic to Outperform From Strong Buy, Price Target Is $14

MT NewswiresOct 29 19:42

Needham Maintains Harmonic(HLIT.US) With Buy Rating, Maintains Target Price $18

Futu NewsOct 29 19:34

Harmonic Price Target Maintained With a $18.00/Share by Needham

Dow JonesOct 29 19:10

Harmonic Analyst Ratings

BenzingaOct 29 19:00

Needham Reiterates Buy on Harmonic, Maintains $18 Price Target

BenzingaOct 29 18:59

Barclays Maintains Harmonic(HLIT.US) With Buy Rating, Cuts Target Price to $17

Futu NewsOct 29 15:32

Harmonic Analyst Ratings

BenzingaOct 16 00:44

Rosenblatt Maintains Buy on Harmonic, Maintains $18 Price Target

BenzingaOct 16 00:44

Harmonic Drive Systems (HSYDF) Was Downgraded to a Sell Rating at Jefferies

TipRanksSep 16 20:20

Hold Rating on Harmonic Drive Systems Amidst Sales Decline and Uncertain Recovery

TipRanksAug 9 23:17

Buy Rating Affirmed for Third Harmonic Bio Amidst Promising Clinical Developments and Market Prospects

TipRanksAug 9 21:07

Third Harmonic Bio Analyst Ratings

BenzingaAug 9 17:28

Buy Rating Justified by Third Harmonic Bio's Promising Drug THB335 and Swift Clinical Advancements

TipRanksAug 9 05:49

Analysts Offer Insights on Healthcare Companies: Aytu BioScience (AYTU), Madrigal Pharmaceuticals (MDGL) and Third Harmonic Bio, Inc. (THRD)

TipRanksAug 8 22:54

Harmonic Price Target Raised to $20.00/Share From $14.00 by Barclays

Dow JonesJul 30 19:47